ADVERTISEMENT
Teva To Buy Allergan Generic Drug Business for $40.5 Bn
27 Jul 2015, 03:53 PM IST i


Representational image
Teva Pharmaceutical Industries has agreed to buy Allergan Plc's generic drugs business for $40.5 billion in a deal that will turn Teva into one of the top 10 pharmaceutical companies.
The acquisition should help Israel-based Teva, already the world's largest generic drugmaker, boost growth at a time its top drug, multiple sclerosis treatment Coxaprone, is facing competition.
Allergan's generic business is generally seen as a better ...
Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit. Feel free to Add NDTV Profit as trusted source on Google.
ADVERTISEMENT